Billis Athanase, Watanabe Isabela C, Costa Matheus V, Telles Gilliat H, Magna Luis A
Anatomic Pathology, School of Medicine, State University of Campinas, Caixa Postal 6111, Campinas 13084-971, Brazil.
Int Urol Nephrol. 2008;40(1):105-11. doi: 10.1007/s11255-007-9198-6. Epub 2007 Jun 30.
There are conflicting data regarding the incidence, site and prognostic significance of positive margins resulting from iatrogenic incision into the prostate (pT2+) or non-iatrogenic inability to excise extraprostatic extension (EPE) of tumor.
The surgical specimens were whole-mount processed. Nerve-sparing, tumor extension and Gleason score were considered possible factors involved in positive margins. Time to PSA progression was studied using a Kaplan-Meier product-limit analysis.
Positive margins resulted from iatrogenic incision in 61/230 (26.52%) prostates and from EPE in 34/230 (14.78%) prostates. The site most frequently involved in pT2+ prostates was the posterolateral quadrants (40.98%); in cases with EPE both anterolateral and posterolateral quadrants (67.65%) were most frequently involved. Positive margins occurred equally in patients with and without nerve-sparing in both groups. Tumors were significantly more extensive and with higher Gleason score in patients with EPE. Time to PSA progression was similar in patients with pT2+ versus EPE and no invasion of the seminal vesicle, but was significantly shorter in patients with EPE and invasion of the seminal vesicle.
The frequency of positive margins in our institution was similar to others with large experience in performing radical prostatectomies. The higher frequency of posterolateral quadrants in iatrogenic positive margins is probably related to the preservation of adjacent vital structures and not to nerve-sparing surgery. A trend for a decreasing frequency of non-iatrogenic surgical margins may be explained by the marked increase of clinical stage T1c in recent years. More-extensive tumors and higher Gleason scores seem to influence only non-iatrogenic positive margins. Biochemical (PSA) progression in EPE must be studied by stratifying the patients into two groups: with and without seminal vesicle invasion.
关于医源性前列腺切开(pT2 +)或非医源性无法切除肿瘤的前列腺外扩展(EPE)导致的切缘阳性的发生率、部位及预后意义,存在相互矛盾的数据。
手术标本进行整装处理。保留神经、肿瘤扩展及Gleason评分被视为可能与切缘阳性有关的因素。使用Kaplan-Meier乘积限界分析研究PSA进展时间。
61/230(26.52%)例前列腺的切缘阳性是由医源性切开导致,34/230(14.78%)例前列腺的切缘阳性是由EPE导致。pT2 +前列腺中最常受累的部位是后外侧象限(40.98%);在EPE病例中,前外侧和后外侧象限均最常受累(67.65%)。两组中保留神经和未保留神经的患者切缘阳性发生率相同。EPE患者的肿瘤范围明显更广,Gleason评分更高。pT2 +与EPE且无精囊侵犯患者的PSA进展时间相似,但EPE且有精囊侵犯患者的PSA进展时间明显更短。
我们机构切缘阳性的频率与其他有大量根治性前列腺切除术经验的机构相似。医源性切缘阳性中后外侧象限频率较高可能与保留相邻重要结构有关,而非与保留神经手术有关。近年来临床分期T1c显著增加可能解释了非医源性手术切缘频率下降的趋势。肿瘤范围更广和Gleason评分更高似乎仅影响非医源性切缘阳性。对于EPE患者的生化(PSA)进展,必须将患者分为有精囊侵犯和无精囊侵犯两组进行研究。